Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

HeartSciences (HSCS) Total Non-Current Liabilities (2022 - 2026)

HeartSciences' Total Non-Current Liabilities history spans 5 years, with the latest figure at $633481.0 for Q1 2026.

  • For Q1 2026, Total Non-Current Liabilities rose 83.17% year-over-year to $633481.0; the TTM value through Jan 2026 reached $633481.0, up 83.17%, while the annual FY2025 figure was $314527.0, 27.54% down from the prior year.
  • Total Non-Current Liabilities reached $633481.0 in Q1 2026 per HSCS's latest filing, up from $247263.0 in the prior quarter.
  • In the past five years, Total Non-Current Liabilities ranged from a high of $4.7 million in Q2 2022 to a low of $247263.0 in Q4 2025.
  • Average Total Non-Current Liabilities over 5 years is $945389.2, with a median of $518056.0 recorded in 2022.
  • Peak YoY movement for Total Non-Current Liabilities: plummeted 73.82% in 2023, then soared 83.17% in 2026.
  • A 5-year view of Total Non-Current Liabilities shows it stood at $549227.0 in 2022, then dropped by 11.35% to $486885.0 in 2023, then decreased by 5.97% to $457814.0 in 2024, then crashed by 45.99% to $247263.0 in 2025, then skyrocketed by 156.2% to $633481.0 in 2026.
  • Per Business Quant, the three most recent readings for HSCS's Total Non-Current Liabilities are $633481.0 (Q1 2026), $247263.0 (Q4 2025), and $281570.0 (Q3 2025).